Format

Send to

Choose Destination
Leukemia. 2018 Dec;32(12):2693-2714. doi: 10.1038/s41375-018-0148-3. Epub 2018 Jun 6.

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial.

Author information

1
Formerly Cardiff University School of Medicine, Cardiff, UK.
2
Centre for Trials Research, Cardiff University, Cardiff, UK. hillsrk@cf.ac.uk.
3
Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
4
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
5
Department of Haematology, Castle Hill Hospital, Hull, UK.
6
Department of Haematology, Blackpool Victoria Hospital, Blackpool, UK.
7
Department of Haematology, Leicester Royal Infirmary, Leicester, UK.
8
Centre for Trials Research, Cardiff University, Cardiff, UK.
9
Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
PMID:
29875430
DOI:
10.1038/s41375-018-0148-3

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center